MétaCan
Menu
Back to cohort
Record W2794162546 · doi:10.1097/mph.0000000000001095

Survival Following Tumor Recurrence in Children With Medulloblastoma

2018· article· en· W2794162546 on OpenAlexaffabout
Donna L. Johnston, Daniel Keene, Douglas Strother, Maria Taneva, Lucie Lafay‐Cousin, Chris Fryer, Katrin Scheinemann, Anne‐Sophie Carret, Adam Fleming, Samina Afzal, Beverly Wilson, Lynette Bowes, Shayna Zelcer, Chris Mpofu, Mariana Silva, Valérie Larouche, Josée Brossard, Éric Bouffet

Bibliographic record

VenueJournal of Pediatric Hematology/Oncology · 2018
Typearticle
Languageen
FieldMedicine
TopicGlioma Diagnosis and Treatment
Canadian institutionsCentre Hospitalier Universitaire de SherbrookeCentre hospitalier universitaire de QuébecSaskatoon City HospitalJaneway Children's Health and Rehabilitation CentreStollery Children's HospitalIzaak Walton Killam Health CentreMontreal Children's HospitalChildren's Hospital of Eastern OntarioChildren's Hospital of Western OntarioHospital for Sick ChildrenPediatric Oncology GroupBC Children's HospitalCentre Hospitalier Universitaire Sainte-JustineMcMaster Children's HospitalKingston General HospitalUniversity of Calgary
Fundersnot available
KeywordsMedulloblastomaMedicineSurvival rateObservational studyStage (stratigraphy)PediatricsBrain tumorOverall survivalSurgeryInternal medicinePathology

Abstract

fetched live from OpenAlex

Medulloblastoma is the most common malignant brain tumor in children. Published survival rates for this tumor are ∼70%; however, there is limited published information on outcome after disease recurrence. This was an observational study which included all persons under the age of 18 years diagnosed with medulloblastoma from 1990 to 2009 inclusive in Canada. Data collected included date of diagnosis, age at diagnosis, sex, stage, pathology, treatment, recurrence, and current status. Survival rates were determined. In total, 550 cases were ascertained meeting the study criteria. The overall survival rate at 1 year was 83.6%±1.7%, at 3 years 77.2%±1.9%, and at 5 years 72.5%±20%. The progression-free survival rates were 78%±1.9%, 70%±2.1%, and 69±2.1% at 1, 3, and 5 years from initial diagnosis. In total, 173 (31.2%) were reported to have had tumor recurrence and 23 (11.4%) of them were alive at the time of survey with an overall survival rate at 1 year of 38.3%±4%, at 2 years of 16.9%±3.3%, and at 5 years of 12.4%±2.8%. Our data confirm that children with recurrent medulloblastoma have a poor prognosis, supporting the need for novel treatment approaches for this group.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.063
Threshold uncertainty score0.125

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.016
GPT teacher head0.310
Teacher spread0.294 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations68
Published2018
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Pediatric Hematology/OncologySame topicGlioma Diagnosis and TreatmentFrench-language works237,207